Clinical trial
Rosuvastatin Pre-Treatment Influences the Risk of Percutaneous Coronary Intervention Study (TIPS-3)
NCT01378715 is registered in ClinicalTrials.gov with University Hospital, Motol as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Rosuvastatin Pre-Treatment Influences the Risk of Percutaneous Coronary Intervention Study (TIPS-3)
- Lead sponsor
- University Hospital, Motol
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- June 30, 2010
- Completion date
- August 31, 2012
- Enrollment
- 400 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.